302 related articles for article (PubMed ID: 6230362)
1. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis.
Pardthaisong T
J Biosoc Sci; 1984 Jan; 16(1):23-34. PubMed ID: 6230362
[TBL] [Abstract][Full Text] [Related]
2. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
Pardthaisong T; Gray RH; McDaniel EB
Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy after removal of Norplant implants contraceptive.
Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
[TBL] [Abstract][Full Text] [Related]
4. Return of fertility in women discontinuing injectable contraceptives.
Fotherby K; Howard G
J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
[TBL] [Abstract][Full Text] [Related]
5. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
7. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
8. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
9. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation.
Pardthaisong T; Yenchit C; Gray R
Contraception; 1992 Apr; 45(4):313-24. PubMed ID: 1387602
[TBL] [Abstract][Full Text] [Related]
10. In utero exposure to steroid contraceptives and outcome of pregnancy.
Pardthaisong T; Gray RH
Am J Epidemiol; 1991 Oct; 134(8):795-803. PubMed ID: 1835282
[TBL] [Abstract][Full Text] [Related]
11. Depo Provera: a profile of current users.
Jarman H; Kovacs GT; Westcott M
Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
[TBL] [Abstract][Full Text] [Related]
12. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
13. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
Colli E; Tong D; Penhallegon R; Parazzini F
Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866
[TBL] [Abstract][Full Text] [Related]
14. Continuation of injectable contraceptives in Thailand.
Narkavonnakit T; Bennett T; Balakrishnan TR
Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
[TBL] [Abstract][Full Text] [Related]
15. In utero exposure to steroid contraceptives and survival during infancy.
Gray RH; Pardthaisong T
Am J Epidemiol; 1991 Oct; 134(8):804-11. PubMed ID: 1835283
[TBL] [Abstract][Full Text] [Related]
16. [Contraception with injectable long-acting preparation depo-provera].
Prilepskaia VN; Kondrikov NI; Tagieva TT
Akush Ginekol (Mosk); 1995; (3):7-10. PubMed ID: 7653732
[TBL] [Abstract][Full Text] [Related]
17. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
19. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
[TBL] [Abstract][Full Text] [Related]
20. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
Potter LS; Dalberth BT; CaƱamar R; Betz M
Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]